Helen Torley: CEO of Halozyme Therapeutics

from BioBoss · host Helen Torley

Helen Torley, CEO of Halozyme Therapeutics, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Halozyme is working to reinvent the patient experience by easing the burden of treatment and improving patient outcomes.

Episode metadata supplied by the publisher feed · Published Mar 25, 2024

Embed this episode

Attribution link and audio player

Ready to play

Helen Torley: CEO of Halozyme Therapeutics

0:00 39:32

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioBoss?

This episode is 39 minutes long.

When was this BioBoss episode published?

This episode was published on March 25, 2024.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this BioBoss episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!